Hypermarcas (OTCMKTS:HYPMY) Stock Price Up 8% – Time to Buy?

Posted by James Conley on Oct 1st, 2026

Shares of Hypermarcas (OTCMKTS:HYPMY – Get Free Report) were up 8% on Thursday. The stock traded as high as $4.99 and last traded at $4.99. 1,842 shares were traded during mid-day trading, a decline of 91% from the average session volume of 19,484 shares. The stock had previously closed at $4.62.

Analysts Set New Price Targets

Separately, Jefferies Financial Group raised Hypermarcas to a “strong-buy” rating in a research report on Monday, July 20th. One research analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Buy”.

View Our Latest Stock Analysis on HYPMY

Hypermarcas Stock Up 3.8%

The business has a 50 day moving average of $4.31 and a two-hundred day moving average of $4.32. The stock has a market capitalization of $3.31 billion, a PE ratio of 9.40 and a beta of 0.71. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.26 and a current ratio of 1.86.

Hypermarcas (OTCMKTS:HYPMY – Get Free Report) last announced its earnings results on Thursday, August 6th. The company reported $0.14 EPS for the quarter, topping analysts’ consensus estimates of $0.13 by $0.01. Hypermarcas had a net margin of 19.77% and a return on equity of 12.68%. Analysts predict that Hypermarcas will post 0.53 EPS for the current year.

About Hypermarcas

(Get Free Report)

Hypermarcas SA was a Brazilian consumer healthcare company that developed, manufactured and marketed pharmaceutical and healthcare products. Its portfolio included over-the-counter medicines, prescription products, vitamins and other consumer health brands sold through pharmacies and retail channels.

The company was historically associated with well-known Brazilian brands such as Benegrip, Biotônico Fontoura, Doril, Engov and Epocler. Hypermarcas also previously operated in personal care, beauty, household cleaning and other consumer categories, but divested many of those businesses as it concentrated on pharmaceuticals and healthcare.

In 2018, Hypermarcas changed its corporate name to Hypera SA, adopting the Hypera Pharma identity.